PLATINUM INVESTMENT MANAGEMENT LTD
Position in IMVT — Immunovant, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in IMVT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,574,173
+$1,058,907 QoQ
Shares Held
144,671
-20.4% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#51
of 224 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. IMVT ranks #3 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $7,740,017 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
154,220 | $5,968,314 | |
| 3 | IMVT |
Immunovant, Inc.
This page
|
144,671 | $5,574,173 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $5,277,935 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
138,708 | $5,169,647 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,878,309 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
90,363 | $4,849,782 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
134,217 | $4,137,910 |
All Filings in IMVT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,574,173 | 144,671 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,515,266 | 181,774 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,620,695 | 181,774 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,155,119 | 195,727 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,131,632 | 195,727 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $2,682,942 | 156,989 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,011,540 | 202,323 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,480,819 | 192,242 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,075,188 | 192,242 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,160,095 | 190,656 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,637,869 | 228,765 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,673,798 | 225,939 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $6,238,132 | 328,842 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,381,504 | 346,970 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,300,521 | 411,297 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,677,638 | 659,075 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,032,601 | 777,590 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,783,496 | 686,660 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,247,468 | 615,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,823,514 | 555,065 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||